WHO: Global Report On Access To Hepatitis C Treatment

The World Health Organization (WHO) recently released, “Global Report On Access To Hepatitis C Treatment: Focus On Overcoming...

Oct 28, 2016 | Kim Rodgers

  • SpeakUP Project: Advancing Health Equity for People Living with HIV

    After five years of being an essential resource center for thousands of people navigating the Affordable Care Act (ACA),...

    Oct 11, 2016 | Kim Rodgers

  • View Now: Webcast on Strategies for Hepatitis B and C Testing and Linkage to Care

    Last week, the Centers for Disease Control and Prevention (CDC) hosted a Public Health Reports Webinar to discuss the strategies for...

    Oct 11, 2016 | Kim Rodgers

  • Lessons from the 2016 Ryan White Conference

    Last month, NACCHO’s HIV, STI, & Viral Hepatitis team attended the 2016 National Ryan White Conference on HIV Care and Treatment....

    Sep 19, 2016 | Kim Rodgers

  • Reminder: OraSure HCV Grant Program Deadline Approaching

    The OraSure HCV Grant Program is a recently announced funding opportunity designed to foster innovative approaches to hepatitis C...

    Aug 22, 2016 | Kim Rodgers

  • CDC Supplemental Appendix: Vulnerability Index for HIV/HCV Outbreak in PWID

    Late last year, the CDC released a vulnerability index which identified six indicators associated with the HIV/Hepatitis C virus (HCV)...

    Aug 04, 2016 | Kim Rodgers

  • World Hepatitis Day: What Local Health Departments Can Do to Address a Global Burden

    World Hepatitis Day— today, July 28—brings awareness to the more than 400 million people across the globe who are infected with...

    Jul 28, 2016 | Kim Rodgers

  • 4th Annual National African American Hepatitis C Action Day

    The National Black Leadership Commission on AIDS, Inc (NLBCA) is commemorating the 4th Annual National African American Hepatitis C...

    Jul 01, 2016 | Kim Rodgers

  • FDA Approves Epclusa for Treatment of Chronic Hepatitis C Infection

    The U.S. Food and Drug Administration recently announced that Epclusa is now approved to treat adult patients with chronic hepatitis C...

    Jul 01, 2016 | Kim Rodgers

  • WHO: Global Report On Access To Hepatitis C Treatment

    The World Health Organization (WHO) recently released, “Global Report On Access To Hepatitis C Treatment: Focus On Overcoming Barriers,” a comprehensive report on the cost of hepatitis C (HCV) therapies and strategies employed by countries at different economic levels to reduce costs. This is the first-ever global report on treatment access to hepatitis C medicines, and it […]

    Oct 28, 2016 | Kim Rodgers

    SpeakUP Project: Advancing Health Equity for People Living with HIV

    After five years of being an essential resource center for thousands of people navigating the Affordable Care Act (ACA), HIVHealthReform.org (HHR) has transitioned into the newly expanded SpeakUP project. SpeakUP is a web-based information hub that identifies health equity issues, related to the Affordable Care Act, that are facing people living with HIV, providers and […]

    Oct 11, 2016 | Kim Rodgers

    View Now: Webcast on Strategies for Hepatitis B and C Testing and Linkage to Care

    Last week, the Centers for Disease Control and Prevention (CDC) hosted a Public Health Reports Webinar to discuss the strategies for hepatitis B and C testing and linkage to care. In alignment with the goals and priorities of CDC’s Division of Viral Hepatitis (DVH) Strategic Plan, 2016–2020: Bringing Together Science and Public-Health Practice for the Elimination of Viral Hepatitis, […]

    Oct 11, 2016 | Kim Rodgers

    Lessons from the 2016 Ryan White Conference

    Last month, NACCHO’s HIV, STI, & Viral Hepatitis team attended the 2016 National Ryan White Conference on HIV Care and Treatment. Sponsored by the U.S. Department of Health and Human Services (HHS), Health Resources and Services Administration (HRSA), HIV/AIDS Bureau (HAB), the conference convened more than 2,400 grantees, consumers, stakeholders, and healthcare professionals from across...

    Sep 19, 2016 | Kim Rodgers

    Reminder: OraSure HCV Grant Program Deadline Approaching

    The OraSure HCV Grant Program is a recently announced funding opportunity designed to foster innovative approaches to hepatitis C (HCV) testing. The program is seeking proposals that demonstrate the effective use of rapid HCV screening in identifying positive individuals in a specific public healthcare setting and linking those individuals into care. Award recipients will receive (up to) 300...

    Aug 22, 2016 | Kim Rodgers

    CDC Supplemental Appendix: Vulnerability Index for HIV/HCV Outbreak in PWID

    Late last year, the CDC released a vulnerability index which identified six indicators associated with the HIV/Hepatitis C virus (HCV) outbreak among people who inject drugs (PWID) in Scott County, Indiana in 2015. Recognizing that this issue extended beyond one locality, CDC assessed the same indicators in 3,143 rural counties across the U.S. to detect jurisdictions that may be […]

    Aug 04, 2016 | Kim Rodgers

    World Hepatitis Day: What Local Health Departments Can Do to Address a Global Burden

    World Hepatitis Day— today, July 28—brings awareness to the more than 400 million people across the globe who are infected with chronic viral hepatitis, including up to 150 million living with hepatitis C virus (HCV). In the United States, more than 3.5 million Americans—particularly baby boomers (those born between 1945 and 1965)—are living with HCV, making it the most common chronic […]

    Jul 28, 2016 | Kim Rodgers

    4th Annual National African American Hepatitis C Action Day

    The National Black Leadership Commission on AIDS, Inc (NLBCA) is commemorating the 4th Annual National African American Hepatitis C Action Day (NAAHCAD) on July 25, 2016. Local health departments and organizations are encouraged to support the day by signing up to host activities in their communities.To encourage participation, organizations who sign up will receive a promotional package...

    Jul 01, 2016 | Kim Rodgers

    FDA Approves Epclusa for Treatment of Chronic Hepatitis C Infection

    The U.S. Food and Drug Administration recently announced that Epclusa is now approved to treat adult patients with chronic hepatitis C virus (HCV), both with and without cirrhosis (advanced liver disease). Read the announcement to learn more about how this decision will widen the scope of treatment options for patients with HCV.

    Jul 01, 2016 | Kim Rodgers

    3 Newsletters1200 1
    Back to Top